These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 3936216

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. [Willebrand's disease and multimeric analysis of the Willebrand factor].
    Hauert J, Tran-Thang C, Bachmann F.
    Schweiz Med Wochenschr; 1985 Dec 07; 115(49):1773-5. PubMed ID: 3879003
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. [Subcutaneous injection of desmopressin (DDAVP) for increasing factor VIII and von Willebrand factor in plasmapheresis].
    Köhler M, Kotitschke R, Braun B, Hellstern P, Mörsdorf S, Pindur G, Heiden M, Wenzel E.
    Beitr Infusionsther; 1990 Dec 07; 26():136-41. PubMed ID: 1703813
    [Abstract] [Full Text] [Related]

  • 49. Variant von Willebrand's disease type B--revisited.
    Howard MA, Salem HH, Thomas KB, Hau L, Perkin J, Coghlan M, Firkin BG.
    Blood; 1982 Dec 07; 60(6):1420-8. PubMed ID: 6814554
    [Abstract] [Full Text] [Related]

  • 50. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG, Ershler WB, Golden EA, Tindle BH, Edson JR.
    Am J Clin Pathol; 1986 Jan 07; 85(1):115-23. PubMed ID: 3079626
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test.
    Mori F, Rossi P, Nardini I, Gambelli D, Farina C.
    Blood Coagul Fibrinolysis; 2010 Apr 07; 21(3):221-8. PubMed ID: 20179578
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factor.
    Foster PA, Fulcher CA, Houghten RA, Zimmerman TS.
    Thromb Haemost; 1990 Jun 28; 63(3):403-6. PubMed ID: 2119526
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Botrocetin (venom coagglutinin): reaction with a broad spectrum of multimeric forms of factor VIII macromolecular complex.
    Brinkhous KM, Read MS, Fricke WA, Wagner RH.
    Proc Natl Acad Sci U S A; 1983 Mar 28; 80(5):1463-6. PubMed ID: 6402781
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. The application of a monoclonal antibody to factor VIII related antigen (VIIIRAg) in immunoradiometric assays for factor VIII.
    Thomas JE, Peake IR, Giddings JC, Welch AN, Bloom AL.
    Thromb Haemost; 1985 Feb 18; 53(1):143-7. PubMed ID: 3922077
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.